Early use of beta-adrenergic-blocking agents in acute myocardial infarction.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Drug Intelligence & Clinical Pharmacy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 2867883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparative study of cardioselective beta-blockade and diazepam in patients wtih acute myocardial infarction and tachycardia.

  2009cited by this paper
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cited by this paper
• Hypokalemia from beta2-receptor stimulation by circulating epinephrine.

  1985cited by this paper
• Göteborg Metoprolol Trial: mortality and causes of death.

  1984cited by this paper
• Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol.

  1984cited by this paper
• Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial.

  1984cited by this paper
• Reduction of infarct size with the early use of timolol in acute myocardial infarction.

  1984cited by this paper
• Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.

  1983cited by this paper
• A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias.

  1983cited by this paper
• Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction.

  1983cited by this paper
• Limitation of myocardial infarct size. Present status.

  1983cited by this paper
• Early intravenous beta-blockade in myocardial infarction.

  1982cited by this paper
• An early intervention secondary prevention study with oxprenolol following myocardial infarction.

  1981cited by this paper
• Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.

  1981cited by this paper
• Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

  1981cited by this paper
• Cause and course of acute myocardial infarction.

  1980cited by this paper
• Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction.

  1980cited by this paper
• In‐hospital Prognosis of Patients with First Nontransmural and Transmural Infarctions

  1980cited by this paper
• Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.

  1980cited by this paper
• Myocardial infarct size. Part I. Basic considerations.

  1980cited by this paper
• Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial.

  1980cited by this paper
• The Effect of Delay in Propranolol Administration on Reduction of Myocardial Infarct Size After Experimental Coronary Artery Occlusion in Dogs

  1979cited by this paper
• Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results.

  1979cited by this paper
• Ventricular arrhythmias and electrophysiological consequences of myocardial ischemia and infarction.

  1978cited by this paper
• Lack of relation between venous plasma total catecholamine concentrations and ventricular arrhythmias after acute myocardial infarction.

  1978cited by this paper
• Reduction of Enzyme Levels by Propranolol After Acute Myocardial Infarction

  1978cited by this paper
• Intravenous and oral practolol in the acute stages of myocardial infarction.

  1978cited by this paper
• Protective effect of propranolol in threatened myocardial infarction.

  1978cited by this paper
• Special article. The role of beta-adrenergic blockade in myocardial infarction.

  1974cited by this paper
• Effect of practolol on the extent of myocardial ischaemic injury after experimental coronary occlusion and its effects of ventricular function in the normal and ischaemic heart.

  1973cited by this paper
• Estimation of Infarct Size in Man and its Relation to Prognosis

  1972cited by this paper
• Autonomic Disturbance at Onset of Acute Myocardial Infarction

  1972cited by this paper
• Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions.

  1972cited by this paper
• Serial Determination of Plasma Catecholamines in Myocardial Infarction

  1972cited by this paper
• Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions

  1971cited by this paper
• Alprenolol in acute myocardial infarction: Double-blind trial.

  1970cited by this paper
• Catecholamine excretion in myocardial infarction.

  1968cited by this paper
• Trial of propranolol in acute myocardial infarction.

  1968cited by this paper
• Clinical Trial of Propranolol in Acute Myocardial Infarction

  1967cited by this paper
• Absence of prophylactic effect of propranolol in myocardial infarction.

  1966cited by this paper
• A controlled trial of propranolol in acute myocardial infarction.

  1966cited by this paper
• Effect of propranolol in myocardial infarction.

  1965cited by this paper
• Adrenergic Effects on Ventricular Vulnerability

  1964cited by this paper

• Pharmacologic and Pharmacokinetic Comparison of Antianginal Agents

  1987cites this paper